Eli Lilly and Company

LLY · Healthcare

About Eli Lilly and Company

Eli Lilly and Company (LLY) has been publicly traded since 1972, making it a 54-year-old public company. It operates in the Drug Manufacturers - General industry within the Healthcare sector. The company is headquartered in Indianapolis, United States and employs approximately 50,000 people. With a market capitalization of $882 billion, LLY is one of the largest publicly traded companies.

Key Statistics

Current Price
$991.30
Market Cap
$887.23B
52-Week High
$1,133.95
52-Week Low
$623.78
Sector
Healthcare
Industry
Drug Manufacturers - General

$1,000 Invested

1 Year
$1,246
+25%
3 Years
$3,199
+220%
5 Years
$5,056
+406%
10 Years
$15,950
+1495%
Since IPO
$1,109,037
+110804%

Monthly Returns Heatmap

Annual Returns

Avg Return
+16.49%
Best Year
1997 (+93.51%)
Worst Year
1992 (-24.88%)
Positive Years
38/54
Year Return Start End
2026 -7.60% $1,072.89 $991.30
2025 +40.25% $765.01 $1,072.89
2024 +33.30% $573.89 $765.01
2023 +60.91% $356.66 $573.89
2022 +34.26% $265.66 $356.66
2021 +66.08% $159.96 $265.66
2020 +31.04% $122.07 $159.96
2019 +16.14% $105.10 $122.07
2018 +40.45% $74.83 $105.10
2017 +17.83% $63.51 $74.83
2016 -10.37% $70.85 $63.51
2015 +25.39% $56.50 $70.85
2014 +39.75% $40.43 $56.50
2013 +7.29% $37.69 $40.43
2012 +24.24% $30.33 $37.69
2011 +25.18% $24.23 $30.33
2010 +3.66% $23.38 $24.23
2009 -6.24% $24.93 $23.38
2008 -21.30% $31.68 $24.93
2007 +5.67% $29.98 $31.68
2006 -5.17% $31.62 $29.98
2005 +2.53% $30.84 $31.62
2004 -17.54% $37.40 $30.84
2003 +13.14% $33.05 $37.40
2002 -17.57% $40.10 $33.05
2001 -14.42% $46.85 $40.10
2000 +41.89% $33.02 $46.85
1999 -24.24% $43.59 $33.02
1998 +29.12% $33.76 $43.59
1997 +93.51% $17.44 $33.76
1996 +32.65% $13.15 $17.44
1995 +77.34% $7.42 $13.15
1994 +15.63% $6.41 $7.42
1993 +2.45% $6.26 $6.41
1992 -24.88% $8.33 $6.26
1991 +16.99% $7.12 $8.33
1990 +9.50% $6.50 $7.12
1989 +64.13% $3.96 $6.50
1988 +12.81% $3.51 $3.96
1987 +7.48% $3.27 $3.51
1986 +36.80% $2.39 $3.27
1985 +75.75% $1.36 $2.39
1984 +19.75% $1.14 $1.36
1983 +5.12% $1.08 $1.14
1982 +7.55% $1.00 $1.08
1981 -8.34% $1.10 $1.00
1980 +11.19% $0.99 $1.10
1979 +29.45% $0.76 $0.99
1978 +30.77% $0.58 $0.76
1977 -17.39% $0.70 $0.58
1976 -5.53% $0.75 $0.70
1975 -22.78% $0.97 $0.75
1974 -6.83% $1.04 $0.97
1973 -6.16% $1.10 $1.04

Valuation

LLY currently trades at a trailing P/E ratio of 42.9, which is considered high relative to the broader market. The forward P/E of 23.5 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 33.2. The price-to-sales ratio is 13.5.

Dividends

Eli Lilly and Company pays a dividend to shareholders with a current yield of 0.63%. This translates to $6.23 per share annually. The payout ratio of 26% indicates sustainable dividend coverage.

Risk & Volatility

LLY has a beta of 0.43, indicating it is less volatile than the overall market. The stock's 52-week range is $623.78 to $1133.95, and it currently trades in the upper half of its 52-week range.

Analyst Ratings

Based on 29 analyst opinions, LLY has a consensus "buy" rating. The average price target of $1216.93 suggests 23.5% upside from current levels.

Frequently Asked Questions

What does Eli Lilly and Company do?

Eli Lilly and Company is a Drug Manufacturers - General company operating in the Healthcare sector. The company is headquartered in Indianapolis, United States.

What sector is LLY in?

LLY operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.

When did LLY go public?

Eli Lilly and Company went public in 1972, making it a 54-year-old public company as of 2026.

How much would $1,000 invested in LLY 5 years ago be worth today?

A $1,000 investment in LLY five years ago would be worth approximately $5,056 today, representing a 405.6% return.

Does LLY pay dividends?

Yes, Eli Lilly and Company pays a dividend with a current yield of 0.63%, which is $6.23 per share annually.

What is LLY's market cap?

Eli Lilly and Company has a market capitalization of $882 billion, classifying it as a mega-cap company.

What is LLY's P/E ratio?

LLY has a trailing P/E ratio of 42.9 and a forward P/E of 23.5, which measures how much investors are paying per dollar of earnings.

Is LLY a buy, hold, or sell?

Based on 29 opinions, LLY has a consensus "buy" rating. The average price target is $1216.93.

Last updated: 3/14/2026